Stockscreener 앱 받기
0.5236
7.52%
-0.0426
전일 마감가:
$0.5662
열려 있는:
$0.58
하루 거래량:
1.11M
Relative Volume:
1.18
시가총액:
$51.72M
수익:
$301.71M
순이익/손실:
$-201.99M
주가수익비율:
-0.2735
EPS:
-1.9144
순현금흐름:
$13.79M
1주 성능:
-8.56%
1개월 성능:
-5.27%
6개월 성능:
-44.30%
1년 성능:
-67.68%
1일 변동 폭
$0.5216
$0.5899
1주일 범위
$0.5216
$0.6262
52주 변동 폭
$0.4913
$1.7799
Docgo Inc Stock (DCGO) Company Profile
명칭
Docgo Inc
전화
(844) 443-6246
주소
685 THIRD AVENUE, NEW YORK
Compare DCGO vs HCA, THC, DVA, FMS, EHC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCGO
Docgo Inc
|
0.5236 | 51.72M | 301.71M | -201.99M | 13.79M | -1.9144 |
HCA
Hca Healthcare Inc
|
375.17 | 83.23B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
172.57 | 14.86B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
207.91 | 13.34B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
23.59 | 12.67B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
98.03 | 9.72B | 6.07B | 793.80M | 464.40M | 5.9914 |
Docgo Inc Stock (DCGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-02-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-08-18 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-04-19 | 개시 | Deutsche Bank | Buy |
| 2022-01-19 | 개시 | Stifel | Buy |
| 2021-12-21 | 개시 | Canaccord Genuity | Buy |
| 2021-12-07 | 개시 | Needham | Buy |
모두보기
Docgo Inc 주식(DCGO)의 최신 뉴스
DocGo shareholders approve reverse stock split and board nominees at annual meeting - Investing.com UK
DocGo Shareholders Approve Reverse Split, Elect Directors - TipRanks
DocGo (NASDAQ: DCGO) holders OK reverse split and reject officer exculpation - Stock Titan
DocGo Inc (DCGO) Institutional Confidence - TradingKey
DocGo Inc (DCGO) Valuation: PE, PB & Fair Value Analysis - TradingKey
DocGo Inc (DCGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
DocGo Inc (DCGO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
DocGo Inc (DCGO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DocGo Inc (DCGO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DocGo Inc (DCGO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DocGo Inc (DCGO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DCGO: Board transitions, proposal approvals, and record growth highlight a pivotal year - TradingView
DocGo Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesSegment Revenue Breakdown - newsline.com
DocGo launches mobile phlebotomy services in southern Florida By Investing.com - Investing.com India
DocGo launches mobile phlebotomy services in southern Florida - Investing.com
DocGo Launches Mobile Phlebotomy Services in South Florida - Business Wire
At-home blood draws come to South Florida as DocGo expands - Stock Titan
DocGo Q1 2026 Earnings: EPS Misses Estimates by 36.55% as Profitability Challenges PersistBuyback Announcement Report - newsline.com
DocGo Inc. (DCGO) Edges Upward Amidst Narrow Trading RangeNegative Gamma - newsline.com
DocGo Q1 2026 Earnings: EPS Misses Estimates as Losses WidenInvestor Earnings Call - thelegaladvocate.com
DocGo (DCGO) price target decreased by 10.71% to 1.91 - MSN
DCGO|DocGo Inc|Price:0.658|Chg%:0.00 - TradingKey
DocGo targets profitability as it pivots to mobile health, medical transport - MSN
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
DocGo Inc. (DCGO) Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesSocial Flow Trades - Newser
DocGo Inc. (DCGO) Navigates Resistance at $0.63 as Shares Edge LowerWeak Sell Signals - thelegaladvocate.com
DocGo outlines $310M-$315M 2026 revenue outlook while targeting 75% mobile phlebotomy growth - MSN
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation Targets - Yahoo Finance
DocGo Targets Profitability as It Pivots to Mobile Health, Medical Transport - sharewise.com
DocGo Inc.Common Stock (NQ: DCGO - The Chronicle-Journal
US$1.87: That's What Analysts Think DocGo Inc. (NASDAQ:DCGO) Is Worth After Its Latest Results - Sahm
DocGo (DCGO) CEO sees 15,644 RSU shares withheld for tax liability - Stock Titan
DocGo Inc. (DCGO) reports Q1 loss, beats revenue estimates - MSN
DocGo Earnings Call: Growth Surges as Margins Strain - TipRanks
Needham Maintains DocGo(DCGO.US) With Buy Rating, Maintains Target Price $3 - Moomoo
CCORF Maintains DocGo(DCGO.US) With Hold Rating, Maintains Target Price $1 - Moomoo
BTIG Maintains DocGo(DCGO.US) With Hold Rating - Moomoo
Needham reiterates DocGo stock rating on SteadyMD strength By Investing.com - Investing.com South Africa
Needham reiterates DocGo stock rating on SteadyMD strength - Investing.com
Docgo Inc (DCGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.63%
0.06%
자본화:
|
볼륨(24시간):